Psyence Biomedical (PBM) Treasury Shares (2024 - 2025)

Psyence Biomedical (PBM) recorded quarterly Treasury Shares of $1.5 million in Q3 2025, up 4165.72% quarter-over-quarter from $34731.0 in Q3 2024, and up 4165.72% on a YoY basis from $34731.0 in Q3 2024.

Psyence Biomedical (PBM) Treasury Shares (2024 - 2025) Analysis & Trends

Psyence Biomedical's Treasury Shares history runs 2 years deep, the most recent figure standing at $1.5 million for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 700,000.00
9 Abivax 91.96 Bn 91.96 Bn - -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 34.70 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 1.48 Mn
Sep 30, 2025 1.48 Mn
Sep 30, 2024 34,731.00
Sep 30, 2024 34,731.00